A 23-year-old man presented to an outside hospital with a 3-day history of dark-colored urine, yellow discoloration of the eyes, and pain in the chest and lumbar area. He denied having confusion, fever, chills, or light-colored stools. He reported consuming small amounts of alcohol once a month and never using tobacco or illicit drugs. His medical history was positive only for anxiety, which was not treated pharmacologically. The patient stated that he had not taken nonprescription medications, herbal supplements, or prescribed medication in the preceding year. Physical examination revealed his vital signs to be within normal limits. Auscultation of the heart was negative for murmurs, the lung fields were clear bilaterally, and the abdomen did not reveal fluid wave, organomegaly, or tenderness. Laboratory test results on admission revealed (normal ranges provided parenthetically): aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels of 2683 U/L (8-48 U/L) and 3496 U/L (7-55 U/L), respectively; an alkaline phosphatase level of 185 U/L (45-115 U/L); and total and direct bilirubin levels of 6.24 mg/dL (0.0-1.2 mg/dL) and 5.1 mg/dL (0.0-0.3 mg/dL), respectively. Urinalysis showed bilirubin but was otherwise unremarkable.
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Viral hepatitis serology test results (hepatitis A antibody total, hepatitis C antibody diagnostic, hepatitis B surface antigen and antibody, envelope antigen and antibody) were negative; an acetaminophen test ruled out toxicity; and iron study results revealed a transferrin saturation of 85% (14%-50%) and a ferritin level of 2000 mcg/L (24-336 mcg/ L). Duplex ultrasound displayed normal appearance of the liver parenchyma and a contracted gallbladder, with no signs of an acute process. A liver biopsy is not essential in the evaluation of all patients with acute liver disease; therefore, less-invasive options should be considered first. A CT scan with contrast may reveal cirrhotic changes, such as a nodular contour, as well as an enlarged left lobe, an atrophied right lobe and splenomegaly, portosystemic shunts, and a re-canalized umbilical vein, if portal hypertension is present. However, a CT scan is not the reference standard for the diagnosis of cirrhosis. A hepatobiliary ultrasound, which is less expensive than a CT scan and does not expose the patient to ionizing radiation, may reveal parenchymal abnormalities and differentiate between cystic and solid lesions. Additionally, the Doppler analysis may yield important information about the hemodynamics of hepatic and portal vessels. However, neither a CT scan nor an ultrasound would help narrow the differential diagnosis.
Typical laboratory abnormalities in Wilson's disease include a high serum copper level, elevated copper levels in 24-hour urine, and a low ratio (<4) of alkaline phosphatase to bilirubin. 1 serum ammonia levels may be seen in advanced liver disease, 2 but the finding is not specific to any particular entity. Our patient had a serum ammonia level of 64 mcmol/L (0-30 mcmol/L). Percutaneous transhepatic cholangiography may be helpful in patients who have biliary obstruction that cannot be addressed with placement of internal stents via endoscopic retrograde cholangio-pancreatography.
Serum and urine copper levels were normal, and a CT scan of the abdomen revealed no focal lesions but was suspicious for fatty liver changes. The initial international normalized ratio was 1.3, and slightly higher (1.6) the next day. All serum immunoglobulin levels were normal. Test results for serum antinuclear antibodies and smooth muscle antibodies were negative. A liver biopsy revealed moderate-to-severe hepatitis with mild cholestasis and no viral inclusions. HFE gene test results for C282Y and H63D mutations were negative, and the elevated ferritin level was interpreted as a nonspecific acute phase reactant. The patient remained stable, and no signs of encephalopathy were observed. Idiopathic acute liver failure describes noneA-E viral liver injury that does not have a known or describable cause. 2 Given that an extensive workup in our patient did not sufficiently explain a specific etiology, describing it as idiopathic was medically appropriate. Budd-Chiari syndrome is a disease of outflow obstruction of the hepatic venous system in which patients may present with acute liver failure. 2 However, duplex ultrasonography did not detect venous thrombus in our patient. A CT scan with contrast can readily identify the disease in most cases. Nonalcoholic steatohepatitis, a subtype of fatty liver disease, may present with abdominal discomfort and elevated liver enzymes and hepatomegaly. 3 A CT scan of the liver may show low attenuation, especially when compared with the spleen, whereas an ultrasound may reveal increased echogenicity, particularly when compared with the renal cortex. Transaminases are usually only moderately elevated in nonalcoholic steatohepatitis. Drug-induced liver injury may be idiosyncratic or predictable, and it can be classified as hepatocellular, cholestatic, or mixed. 4 Although signs and symptoms may not differ from those in other forms of hepatitis, the clinical history of present illness and medication reconciliation is very important. Our patient had not taken medications, ingested harmful substances, or used illicit drugs. Autoimmune hepatitis is typically diagnosed with serology tests. However, these tests are not always definitive and liver biopsy may be needed. Hypergammaglobulinemia is present in approximately 80% of cases. 3 Our patient had a negative autoimmune workup, and serum immunoglobulin levels were normal, although patients with severe cases may not have elevated IgG levels.
Serum transaminases reached a plateau within 5 days, and then began to fall, which correlated with clinical improvement and recovery. The patient was discharged in stable condition and underwent biweekly follow-up laboratory tests. Approximately 5 weeks later, his AST was 445 U/L, and his ALT was 511 U/ L. Although he remained asymptomatic, a progressive decline in hemoglobin levels, white blood cell count, and platelet count was observed, and a hematologist was consulted regarding progressive pancytopenia. An elevated LDH level aids in the diagnosis of hemolytic anemia, which may be accompanied by jaundice and indirect hyperbilirubinemia. 5 The patient experienced improvement in liver function and showed no signs of hemolysis, as his bilirubin returned to a normal range. Immune thrombocytopenia is often a diagnosis of exclusion and does not explain the drop in the red and white blood cell counts.
Antiplatelet antibodies are not routinely used in the diagnosis. The serum haptoglobin level is low or undetectable not only when a patient is hemolyzing, but also in those who have liver disease. 5 Our patient had a very high haptoglobin level, which was likely secondary to its role as an acute phase reactant. A bone marrow aspiration and/or biopsy is needed in the evaluation of unexplained pancytopenia. 6 Macrocytic anemia may be caused by myelodysplastic syndrome, leading to abnormal red blood cell maturation. Vitamin B12 and folate are necessary for nucleic acid metabolism in erythroid precursors. Certain antiretroviral drugs are known to cause macrocytic anemia. 5 Macrocytic anemia concomitant with thrombocytopenia or leukopenia and lymphopenia is indicative of a myeloid disorder.
A test of LDH revealed a level of 220 U/L (122-222 U/L), a vitamin B12 level of 599 ng/L (180-914 ng/L), and folate at 13.5 mcg/ L (low 4 mcg/L). The bone marrow biopsy showed hypocellular marrow with 20% cellularity and decreased trilineage hematopoiesis, suggestive of severe aplastic anemia (AA). Fanconi anemia is a congenital form of stem-cell failure that occurs as a result of chromosomal breaks in lymphocytes. 6 This disease may present in adult life, but it is often diagnosed during childhood. A high percentage of cases of AA are caused by an undesirable drug effect. Prescription and recreational drugs need to be included in the differential diagnosis of pancytopenia. 6 After hospital discharge, our patient used only low-dose acetaminophen, with frequent and close follow-up visits with his physicians. Paroxysmal nocturnal hemoglobinuria has been linked to AA resulting from a clonal disorder. Hemolysis may be present, as well as thromboembolism of the venous system, but it is rare in younger individuals. 6 Myelodysplastic syndrome is a heterogeneous group of neoplastic hematopoietic stem-cell disorders characterized by dysplastic and ineffective blood cell production and a variable risk of transformation to acute leukemia. The syndrome usually presents later in life, but it may be seen in younger patients, making chromosomal studies very important. 6 IHAAA refers to a seronegative hepatitis, occurring most commonly in young males, from which patients recover as expected, only to present later with AA. 7, 8 This was the accepted diagnosis for our patient, as all other conditions, common and rare, had been excluded.
The patient was initially seen on an outpatient basis, since his laboratory test result abnormalities were not at critical values. However, a few days later, he reported to the emergency department with bleeding gums. A complete blood cell count showed a hemoglobin value of 6.5 g/dL and a platelet count of 4 x 10 9 /L. The patient was transfused with a unit of platelets and packed red blood cells. The first option, IST, particularly the combination of antithymocyte globulin (ATG), cyclosporine, and steroids, is a safe alternative when a matched donor is not found, and can also serve as a bridge to stem-cell transplantation. [7] [8] [9] HSCT is the most appropriate approach as it offers the best survival benefit, but is limited by the need of a human leukocyte antigenematched donor. 9 After the first hospitalization, the liver enzymes stabilized, the international normalized ratio decreased to 1.1, and the patient remained free of encephalopathy and other features of liver failure. Therefore, urgent liver transplantation was not recommended. Also, his AA was believed to be the result of hepatitis, and not an incidental comorbidity. Unfortunately, some patients may respond to IST slowly, if at all. Therefore, an alternative therapy is needed in this population. Thrombopoietic agents, in particular eltrombopag, have been found to increase the platelet count of patients who have refractory AA. 10 Serial transfusions, although likely needed in the course of AA, would not be the best long-term treatment. All patients with AA should be monitored for critical laboratory test findings, as significant morbidity and mortality are associated with bleeding and infection. 10 A human leukocyte antigenematched donor for our patient was not found, and a course of IST with ATG was administered along with daily, high-dose cyclosporine, eltrombopag, and steroids. Platelet and packed red blood cell transfusions were given as needed. The patient developed severe sepsis due to pneumonia, likely secondary to AA-associated immunodeficiency. The patient had an extended stay in the intensive care unit; however, he eventually recovered from sepsis and was discharged to home on daily cyclosporine, eltrombopag, and prophylactic antibiotics, with scheduled laboratory tests and follow-up appointments with the hematology and transplant hepatology clinics.
DISCUSSION
Idiopathic hepatitis-associated AA is a disease characterized by acute and usually severe liver disease with a recovery phase. During or after this recovery phase, patients may develop AA, although it is typically seen weeks or even years later 7, 11, 12 and is usually first noticed as progressive pancytopenia. The symptoms include pallor, skin bleeding, fatigue, dizziness, and severe infection. A thorough workup is required since IHAAA is a diagnosis of exclusion, with severe and otherwise unexplained hematologic abnormalities that lead to bone marrow biopsy. 6 Brown et al 7 proposed the idea of an immune-mediated process, because high counts of activated cluster of differentiation (CD) 8 cells, and a low CD4/CD8 ratio, were found in the blood of each of their patients. In a review, Rauff et al 12 suggested that these CD 8 cells promote cytotoxic T-cell activation and accumulation in the liver via the secretion of interferon gamma. 12 A study of nearly 4000 patients who had AA, conducted by the European Blood and Marrow Transplant Group, revealed the incidence of IHAAA to be 5% over a period of 17 years. 11 The study found that IHAAA was more prevalent in young men; no significant associations with genetics, variation in time of onset, or socioeconomic background were found in the study. However, in regard to prognosis, age greater than 20 years and delayed treatments were found to be predictors of poor outcome.
Hematopoietic stem-cell transplant, which has improved long-term survival in these patients, is the treatment of choice for IHAAA. 9 IST is used as a bridge to HSCT, or as the primary therapy when HSCT cannot be performed. The therapy is comprised of a short course of ATG, with daily, high-dose cyclosporine and eltrombopag for maintenance therapy and sustained remission. 8, 9 Once IST is initiated, recovery of liver function is hastened, which also suggests an immunemediated etiology. 7, 8 Response time to therapy is variable. Platelet counts and hemoglobin levels may repeatedly reach critical thresholds, necessitating packed red blood cell and platelet transfusions; hence, frequent monitoring of blood counts is recommended. Patients who have AA have an acquired immunodeficiency and are more susceptible to infection compared with the general population. 6 Prophylactic antimicrobial therapy should be considered and its benefit weighed against the risk of antibiotic-induced marrow suppression. Growth factors, particularly thrombopoietics are typically employed in refractory AA to recover cell counts and reduce transfusion frequency. 10 However, these agents are not curative. Counseling the patient on these therapies and their potential adverse effects (eg, graft rejection, immunosuppression, long-term steroid use), as well as on the importance of adherence, is extremely important and should be conducted early in the clinical course.
CONCLUSION
Idiopathic hepatitis-associated AA is a serious and potentially life-threatening condition in which progressive pancytopenia may develop weeks or even months after an initial recovery phase. Prompt treatment with IST and HSCT can substantially improve outcomes.
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